Key statistics
On Tuesday, Evotec SE (0IRF:LSE) closed at 5.91, 20.56% above the 52 week low of 4.90 set on Aug 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.93 |
---|---|
High | 5.91 |
Low | 5.91 |
Bid | -- |
Offer | -- |
Previous close | 5.91 |
Average volume | 114.71k |
---|---|
Shares outstanding | 177.55m |
Free float | 175.77m |
P/E (TTM) | -- |
Market cap | 1.07bn EUR |
EPS (TTM) | -0.9634 EUR |
Data delayed at least 15 minutes, as of Oct 08 2024 17:13 BST.
More ▼
- EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-DD: Evotec SE: Laetitia Rouxel, Restricted shares granted as Short-Term Variable Incentive (Bonus) for 2023 pursuant Evotec’s remuneration system
- EQS-News: Evotec and Novo Nordisk enter into technology development partnership to support next-generation cell therapies
- EQS-News: Just – Evotec Biologics opens cutting-edge biologics facility - J.POD® Toulouse, France (EU)
- EQS-DD: Evotec SE: Dr. Christian Wojczewski, buy
- EQS-DD: Evotec SE: Aurélie Dalbiez, buy
- EQS-News: Evotec announces change in Management Board
- EQS-DD: Evotec SE: Prof. Dr. Iris Löw-Friedrich, buy
- EQS-DD: Evotec SE: Dr. Craig Johnstone, buy
- EQS-News: Evotec SE reports H1 2024 results: Challenging year; priority reset for sustainable profitable growth gaining momentum, building on core strengths
More ▼